Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
38 studies found for:    Amenorrhea: Clinical Trials
Show Display Options
Download search resultsDownload the search results for:
Amenorrhea: Clinical Trials (38 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Condition: Amenorrhea
Interventions: Drug: DR-2021a;   Drug: DR-2021b;   Drug: DR-2021c;   Drug: DR-2021d;   Drug: DR-2021e;   Other: Placebo
2 Terminated A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
Condition: Secondary Amenorrhea
Intervention: Drug: Progesterone
3 Terminated
Has Results
The Luveris In Vitro Fertilization Trial
Conditions: Infertility;   Hypothalamic Amenorrhea;   Hyperprolactinemia
Interventions: Drug: Luveris fixed dose;   Drug: Luveris increasing dose
4 Active, not recruiting Study of Leptin for the Treatment of Hypothalamic Amenorrhea
Condition: Amenorrhea
Interventions: Drug: r-metHuLeptin;   Drug: Oral Contraceptive Pills (OCPs)
5 Active, not recruiting Analgesic Effect of Maternal Breast Milk Odor in Preterm Neonates: a Randomised Controlled Trial
Condition: Neonates Analgesy
Interventions: Other: maternal breast milk odor;   Other: no odor
6 Unknown  CavatermTM vs TCRE in Women With DUB
Condition: Dysfunctional Uterine Bleeding
Interventions: Device: Thermal Balloon Endometrial Ablation;   Device: Transcervical Resection of the Endometrium
7 Recruiting Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
Condition: Breast Cancer Nos Premenopausal
Interventions: Drug: Docetaxel;   Drug: epirubicin;   Drug: cyclophosphamide;   Procedure: Modified radical mastectomy or breast-conserving Surgery;   Drug: Docetaxel (post-operative);   Drug: Epirubicin (post-operative);   Drug: Cyclophosphamide (post-operative);   Radiation: Radiation therapy;   Drug: Herceptin (post-operative);   Drug: Tamoxifen (post-operative)
8 Recruiting Anti-Mullerian Hormone Study. ICORG 10-16, V2
Conditions: Premenopausal Breast Cancer;   Breast Cancer
Intervention:
9 Unknown  Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses
Condition: Gastroschisis
Intervention: Procedure: AMNIOECHANGE
10 Completed Effect of Hormone Replacement Therapy on Lupus Activity
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
11 Completed Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion
Condition: Intrauterine Adhesion
Interventions: Device: Crosslinked hyaluronic acid gel;   Device: Foleys balloon catheter
12 Recruiting A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).
Condition: Contraception
Interventions: Drug: Levonorgestrel (13,5 mg) intrauterine device;   Device: Cooper (380mm2) intrauterine device
13 Completed Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
Conditions: Breast Cancer;   Infertility;   Menopausal Symptoms
Interventions: Drug: cyclophosphamide;   Drug: goserelin acetate;   Procedure: adjuvant therapy;   Procedure: fertility assessment and management;   Procedure: neoadjuvant therapy
14 Completed Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis
Condition: the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis
Intervention: Drug: received oral letrozole (2.5 mg/day)and goserelin subcutaneosly (3.6 mg/month)
15 Completed A Study to Compare the Effectiveness of Two Different Outpatient Endometrial Ablation Techniques Used for Heavy Periods
Condition: Menorrhagia
Interventions: Device: NovaSure;   Device: thermachoice
16 Recruiting Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Non-Alcoholic Fatty Liver Disease;   Metabolic Syndrome
Interventions: Drug: Metformin;   Drug: Placebo
17 Active, not recruiting Efficacy of the Female Athlete Body Project (FAB)
Conditions: Eating Disorders;   Female Athlete Triad
Interventions: Behavioral: Healthy Weight;   Other: Brochure
18 Completed
Has Results
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin
19 Unknown  Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
Condition: Menopause
Intervention: Drug: Hormone Replacement Therapy
20 Completed Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers
Condition: Placenta Vascular Malformation
Intervention: Other: blood sample

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.